2020 Form 10-K Financial Statement

#000086627320000109 Filed on September 03, 2020

View on sec.gov

Income Statement

Concept 2020 2019 Q2 2019 Q1
Revenue $1.101B $398.7M $358.9M
YoY Change -22.29% 36.04% 46.1%
Cost Of Revenue $998.8M $355.0M $322.0M
YoY Change -22.26% 30.71% 39.53%
Gross Profit $102.2M $43.74M $36.91M
YoY Change -22.57% 103.9% 147.84%
Gross Profit Margin 9.28% 10.97% 10.28%
Selling, General & Admin $86.28M $26.30M $24.11M
YoY Change -8.24% 27.67% 16.19%
% of Gross Profit 84.44% 60.13% 65.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $19.12M $4.600M $4.490M
YoY Change 4.94% -4.17% -3.23%
% of Gross Profit 18.72% 10.52% 12.17%
Operating Expenses $86.28M $26.30M $24.11M
YoY Change -8.24% 27.67% 16.19%
Operating Profit -$36.63M $17.39M $12.79M
YoY Change -196.56% -201.62% -318.25%
Interest Expense $1.597M $0.00 $301.0K
YoY Change 23.23% -100.0% -53.19%
% of Operating Profit 0.0% 2.35%
Other Income/Expense, Net $308.0K $0.00 $58.00K
YoY Change -49.59% -100.0% -84.32%
Pretax Income -$36.64M $17.40M $12.86M
YoY Change -195.4% -200.58% -314.12%
Income Tax -$3.570M $4.600M $3.925M
% Of Pretax Income 26.44% 30.53%
Net Earnings -$33.07M $12.81M $8.933M
YoY Change -218.2% -187.26% -273.36%
Net Earnings / Revenue -3.0% 3.21% 2.49%
Basic Earnings Per Share -$1.24 $0.48 $0.33
Diluted Earnings Per Share -$1.24 $0.47 $0.33
COMMON SHARES
Basic Shares Outstanding 26.62M shares 26.81M shares 26.79M shares
Diluted Shares Outstanding 26.62M shares 27.42M shares

Balance Sheet

Concept 2020 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.0M $89.70M $49.70M
YoY Change 11.48% 39.94% 5.97%
Cash & Equivalents $100.0M $89.72M $49.68M
Short-Term Investments
Other Short-Term Assets $4.500M $5.034M $6.171M
YoY Change -10.0% 12.92% -9.41%
Inventory $6.500M $8.017M $8.637M
Prepaid Expenses
Receivables $220.2M $218.4M $274.9M
Other Receivables $3.900M $0.00 $400.0K
Total Short-Term Assets $335.2M $417.3M $415.2M
YoY Change -19.67% 16.88% 29.43%
LONG-TERM ASSETS
Property, Plant & Equipment $102.1M $79.34M $75.81M
YoY Change 28.75% 9.21% 1.93%
Goodwill $93.37M $93.32M
YoY Change -2.91% -17.87%
Intangibles $19.47M $20.28M
YoY Change -14.65% -17.01%
Long-Term Investments
YoY Change
Other Assets $10.80M $21.23M $20.62M
YoY Change -54.81% 369.81% 892.97%
Total Long-Term Assets $182.1M $216.1M $216.2M
YoY Change -15.73% 7.51% -1.02%
TOTAL ASSETS
Total Short-Term Assets $335.2M $417.3M $415.2M
Total Long-Term Assets $182.1M $216.1M $216.2M
Total Assets $517.3M $633.4M $631.4M
YoY Change -18.33% 13.5% 17.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $73.10M $114.6M $110.5M
YoY Change -36.21% 44.32% 63.45%
Accrued Expenses $39.00M $52.70M $55.90M
YoY Change -26.0% 37.6% 46.34%
Deferred Revenue $105.6M -$122.2M
YoY Change -187.48%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $175.9M $275.5M $289.5M
YoY Change -36.15% 15.53% 48.93%
LONG-TERM LIABILITIES
Long-Term Debt $9.200M $5.347M $2.172M
YoY Change 73.58% -76.66%
Other Long-Term Liabilities $24.20M $293.0K $200.0K
YoY Change 7966.67% -2.33% -33.33%
Total Long-Term Liabilities $33.40M $5.640M $2.172M
YoY Change 496.43% -76.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $175.9M $275.5M $289.5M
Total Long-Term Liabilities $33.40M $5.640M $2.172M
Total Liabilities $209.4M $281.4M $295.3M
YoY Change -25.59% 17.66% 42.46%
SHAREHOLDERS EQUITY
Retained Earnings $239.5M $226.7M
YoY Change 13.23% 0.22%
Common Stock $279.0K $279.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $17.76M $17.82M
YoY Change 0.24% -2.96%
Treasury Stock Shares 1.081M shares 1.085M shares
Shareholders Equity $307.9M $352.0M $336.1M
YoY Change
Total Liabilities & Shareholders Equity $517.3M $633.4M $631.4M
YoY Change -18.33% 13.5% 17.1%

Cashflow Statement

Concept 2020 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$33.07M $12.81M $8.933M
YoY Change -218.2% -187.26% -273.36%
Depreciation, Depletion And Amortization $19.12M $4.600M $4.490M
YoY Change 4.94% -4.17% -3.23%
Cash From Operating Activities $44.09M $42.51M -$14.60M
YoY Change 6.5% 47.76% -189.46%
INVESTING ACTIVITIES
Capital Expenditures $18.54M -$5.840M -$7.660M
YoY Change -5.21% 128.12% 264.76%
Acquisitions $0.00
YoY Change
Other Investing Activities $1.420M $170.0K $130.0K
YoY Change -72.21% -15.0% -70.45%
Cash From Investing Activities -$17.12M -$5.670M -$7.530M
YoY Change 18.47% 140.25% 353.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $17.05M
YoY Change 228.42%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$16.04M 3.110M 240.0K
YoY Change 1348.87% -134.56% -100.58%
NET CHANGE
Cash From Operating Activities $44.09M 42.51M -14.60M
Cash From Investing Activities -$17.12M -5.670M -7.530M
Cash From Financing Activities -$16.04M 3.110M 240.0K
Net Change In Cash $10.32M 39.95M -21.89M
YoY Change -59.77% 129.47% -19.05%
FREE CASH FLOW
Cash From Operating Activities $44.09M $42.51M -$14.60M
Capital Expenditures $18.54M -$5.840M -$7.660M
Free Cash Flow $25.55M $48.35M -$6.940M
YoY Change 16.99% 54.32% -137.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 mtrx Other Treasury Shares Acquired
OtherTreasurySharesAcquired
52950 shares
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000866273
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-88000 USD
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
27000 USD
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-24000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
905000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
923000 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27888217 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27888217 shares
CY2020 dei Entity Registrant Name
EntityRegistrantName
MATRIX SERVICE CO
CY2020Q2 us-gaap Shares Outstanding
SharesOutstanding
26141528 shares
CY2019Q2 us-gaap Shares Outstanding
SharesOutstanding
26807203 shares
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1746689 shares
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1081014 shares
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2020 mtrx Deferred Shares Issued
DeferredSharesIssued
542279 shares
CY2020 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
20733 shares
CY2020 mtrx Other Treasury Shares Acquired
OtherTreasurySharesAcquired
181081 shares
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1047606 shares
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12500 shares
CY2019 mtrx Deferred Shares Issued
DeferredSharesIssued
314711 shares
CY2019 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
15812 shares
CY2019 mtrx Other Treasury Shares Acquired
OtherTreasurySharesAcquired
79111 shares
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
310532 shares
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31050 shares
CY2018 mtrx Deferred Shares Issued
DeferredSharesIssued
253241 shares
CY2018 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
21920 shares
CY2018 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
200000 USD
CY2018 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
500000 USD
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-300000 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000 USD
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6200000 USD
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-15461
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26460196 shares
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
73-1352174
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
5100 E. Skelly Drive,
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 500
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74135
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa,
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
CY2020 dei City Area Code
CityAreaCode
918
CY2020 dei Local Phone Number
LocalPhoneNumber
838-8822
CY2020 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2020 dei Trading Symbol
TradingSymbol
MTRX
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Public Float
EntityPublicFloat
599000000 USD
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
CY2020Q2 mtrx Goodwill Attributable To Reporting Units At Risk For Impairment
GoodwillAttributableToReportingUnitsAtRiskForImpairment
14200000 USD
CY2020 us-gaap Revenues
Revenues
1100938000 USD
CY2019 us-gaap Revenues
Revenues
1416680000 USD
CY2018 us-gaap Revenues
Revenues
1091553000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
998762000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1284729000 USD
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
999617000 USD
CY2020 us-gaap Gross Profit
GrossProfit
102176000 USD
CY2019 us-gaap Gross Profit
GrossProfit
131951000 USD
CY2018 us-gaap Gross Profit
GrossProfit
91936000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86276000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
94021000 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
84417000 USD
CY2020 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
38515000 USD
CY2019 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2018 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
17998000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
14010000 USD
CY2019 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2018 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-36625000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
37930000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-10479000 USD
CY2020 us-gaap Interest Expense
InterestExpense
1597000 USD
CY2019 us-gaap Interest Expense
InterestExpense
1296000 USD
CY2018 us-gaap Interest Expense
InterestExpense
2600000 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1270000 USD
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
1167000 USD
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
381000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
308000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
611000 USD
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
550000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36644000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38412000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12148000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3570000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10430000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-668000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-33074000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
27982000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-11480000 USD
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26621000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26891000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26769000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26621000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27587000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26769000 shares
CY2020 us-gaap Profit Loss
ProfitLoss
-33074000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
27982000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-11480000 USD
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-622000 USD
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-340000 USD
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-87000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-33696000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
27642000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-11567000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100036000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89715000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
160671000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
218432000 USD
CY2020Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
59548000 USD
CY2019Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
96083000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
6460000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
8017000 USD
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3919000 USD
CY2019Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
29000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4526000 USD
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5034000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
335160000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
417310000 USD
CY2020Q2 mtrx Land Buildings And Improvements Gross
LandBuildingsAndImprovementsGross
42695000 USD
CY2019Q2 mtrx Land Buildings And Improvements Gross
LandBuildingsAndImprovementsGross
41179000 USD
CY2020Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
94154000 USD
CY2019Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
91793000 USD
CY2020Q2 mtrx Transportation Equipment Gross
TransportationEquipmentGross
55864000 USD
CY2019Q2 mtrx Transportation Equipment Gross
TransportationEquipmentGross
52526000 USD
CY2020Q2 mtrx Office Equipment And Capitalized Computer Software Gross
OfficeEquipmentAndCapitalizedComputerSoftwareGross
39356000 USD
CY2019Q2 mtrx Office Equipment And Capitalized Computer Software Gross
OfficeEquipmentAndCapitalizedComputerSoftwareGross
43632000 USD
CY2020Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4427000 USD
CY2019Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
7619000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
236496000 USD
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
236749000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
155748000 USD
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
157414000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80748000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
79335000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21375000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2020Q2 us-gaap Goodwill
Goodwill
60369000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
93368000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8837000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19472000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5988000 USD
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2683000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4833000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21226000 USD
CY2020Q2 us-gaap Assets
Assets
517310000 USD
CY2019Q2 us-gaap Assets
Assets
633394000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
73094000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
114647000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
63889000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
105626000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16205000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38357000 USD
CY2020Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
7301000 USD
CY2019Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
9021000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7568000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2019Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2517000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7890000 USD
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5331000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
175947000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
275499000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
61000 USD
CY2019Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
298000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19997000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
9208000 USD
CY2019Q2 us-gaap Line Of Credit
LineOfCredit
5347000 USD
CY2020Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
4208000 USD
CY2019Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
293000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
209421000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
281437000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
279000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
279000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138966000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
137712000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
206402000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
239476000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8373000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-7751000 USD
CY2020Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
337274000 USD
CY2019Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
369716000 USD
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
29385000 USD
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
17759000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
307889000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351957000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
517310000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
633394000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-33074000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
27982000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-11480000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19124000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18224000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20347000 USD
CY2020 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
38515000 USD
CY2019 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2018 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
17998000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
9877000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
11908000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
8618000 USD
CY2020 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
5215000 USD
CY2019 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
CY2018 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
CY2020 mtrx Deferred Income Tax Expense Benefit Socf
DeferredIncomeTaxExpenseBenefitSocf
-3630000 USD
CY2019 mtrx Deferred Income Tax Expense Benefit Socf
DeferredIncomeTaxExpenseBenefitSocf
2061000 USD
CY2018 mtrx Deferred Income Tax Expense Benefit Socf
DeferredIncomeTaxExpenseBenefitSocf
-1186000 USD
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
427000 USD
CY2018 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
767000 USD
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
854000 USD
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
662000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1158000 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-701000 USD
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-397000 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
107000 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
7000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-56603000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15374000 USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5504000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-36535000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
19809000 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-14548000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1557000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2872000 USD
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1415000 USD
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-11029000 USD
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12246000 USD
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-369000 USD
CY2020 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
320000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-38915000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
32651000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-25883000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-41737000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-14983000 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
45613000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-17398000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14427000 USD
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1796000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44085000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41394000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74671000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18539000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19558000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8711000 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1687000 USD
CY2020 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2019 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
3885000 USD
CY2018 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1423000 USD
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1225000 USD
CY2018 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1062000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17116000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14448000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9336000 USD
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
18567000 USD
CY2019 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
16225000 USD
CY2018 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
85317000 USD
CY2020 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
14357000 USD
CY2019 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
10896000 USD
CY2018 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
130248000 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
364000 USD
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17045000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5190000 USD
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
128000 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
317000 USD
CY2019 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
311000 USD
CY2018 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
293000 USD
CY2020 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
3524000 USD
CY2019 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
1685000 USD
CY2018 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
627000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16039000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1107000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45312000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-609000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-181000 USD
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
229000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10321000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25658000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20252000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89715000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64057000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43805000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100036000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89715000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64057000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6394000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3309000 USD
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1410000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
2148000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1705000 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
2719000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
48000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2686000 USD
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
156000 USD
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
321809000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-11480000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-87000 USD
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
293000 USD
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
317000 USD
CY2018 mtrx Issuance Of Deferred Shares
IssuanceOfDeferredShares
0 USD
CY2018 mtrx Other Treasury Share Purchases
OtherTreasurySharePurchases
627000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8618000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
318843000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
27982000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-340000 USD
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
311000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
128000 USD
CY2019 mtrx Issuance Of Deferred Shares
IssuanceOfDeferredShares
0 USD
CY2019 mtrx Other Treasury Share Purchases
OtherTreasurySharePurchases
1685000 USD
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-5190000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11908000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351957000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-33074000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-622000 USD
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
320000 USD
CY2020 mtrx Issuance Of Deferred Shares
IssuanceOfDeferredShares
0 USD
CY2020 mtrx Other Treasury Share Purchases
OtherTreasurySharePurchases
3524000 USD
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-17045000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9877000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
307889000 USD
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-align:justify;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We believe the most significant estimates and judgments are associated with revenue recognition, the recoverability tests that must be periodically performed with respect to our goodwill and other intangible assets, valuation reserves on our accounts receivable and deferred tax assets, and the estimation of loss contingencies, including liabilities associated with litigation and with the self-insured retentions on our insurance programs. Actual results could materially differ from those estimates.</span></div>
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24600000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
25800000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
566400000 USD
CY2020Q2 mtrx Performanceobligationstoberecognizedasrevenuewithinnexttwelvemonths
Performanceobligationstoberecognizedasrevenuewithinnexttwelvemonths
429000000.0 USD
CY2020Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
59548000 USD
CY2019Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
96083000 USD
CY2020 mtrx Changein Cie
ChangeinCIE
-36535000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
63889000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
105626000 USD
CY2020 mtrx Changein Bie
ChangeinBIE
41737000 USD
CY2020Q2 mtrx Contract With Customer Current Liability Net
ContractWithCustomerCurrentLiabilityNet
-4341000 USD
CY2019Q2 mtrx Contract With Customer Current Liability Net
ContractWithCustomerCurrentLiabilityNet
-9543000 USD
CY2020 mtrx Changeinnetcontractbalances
Changeinnetcontractbalances
5202000 USD
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
104400000 USD
CY2020Q2 us-gaap Construction Contractor Receivable Retainage Year One
ConstructionContractorReceivableRetainageYearOne
37300000 USD
CY2019Q2 us-gaap Construction Contractor Receivable Retainage Year One
ConstructionContractorReceivableRetainageYearOne
21900000 USD
CY2020Q2 us-gaap Construction Contractor Receivable Retainage After Year One
ConstructionContractorReceivableRetainageAfterYearOne
1600000 USD
CY2019Q2 us-gaap Construction Contractor Receivable Retainage After Year One
ConstructionContractorReceivableRetainageAfterYearOne
17700000 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1100938000 USD
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1416680000 USD
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1091553000 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1100938000 USD
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1416680000 USD
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1091553000 USD
CY2017Q2 us-gaap Goodwill
Goodwill
113501000 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-17281000 USD
CY2018 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-58000 USD
CY2018Q2 us-gaap Goodwill
Goodwill
96162000 USD
CY2019 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
-2775000 USD
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-19000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
93368000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-32881000 USD
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-118000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
60369000 USD
CY2020Q2 mtrx Goodwill Attributable To Reporting Units At Risk For Impairment
GoodwillAttributableToReportingUnitsAtRiskForImpairment
14200000 USD
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
700000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
25872000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17035000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8837000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
42604000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23132000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19472000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3300000 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4800000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2231000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1811000 USD
CY2020 mtrx Sublimiton Australian Dollar Canadian Dollar Euroand Pounds Sterling
SublimitonAustralianDollarCanadianDollarEuroandPoundsSterling
75.0 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1729000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1415000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1096000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
555000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8837000 USD
CY2020Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
300000000.0 USD
CY2020 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2022-02-08
CY2020 mtrx Sublimitonlettersofcreditunderthecreditfacility
Sublimitonlettersofcreditunderthecreditfacility
200.0 USD
CY2020 mtrx Line Of Credit Basis Spread On Alternate Base Rate Minimum
LineOfCreditBasisSpreadOnAlternateBaseRateMinimum
0.00625 Rate
CY2020 mtrx Line Of Credit Basis Spread On Alternate Base Rate Maximum
LineOfCreditBasisSpreadOnAlternateBaseRateMaximum
0.01625 Rate
CY2020 mtrx Line Of Credit Basis Spread On Adjusted Liboeurib Oand Cdor Minimum
LineOfCreditBasisSpreadOnAdjustedLIBOEURIBOandCDORMinimum
0.01625 Rate
CY2020 mtrx Line Of Credit Basis Spread On Adjusted Liboeurib Oand Cdor Maximum
LineOfCreditBasisSpreadOnAdjustedLIBOEURIBOandCDORMaximum
0.02625 Rate
CY2020 mtrx Line Of Credit Basis Spread On Canadian Prime Rate Minimum
LineOfCreditBasisSpreadOnCanadianPrimeRateMinimum
0.02125 Rate
CY2020 mtrx Line Of Credit Basis Spread On Canadian Prime Rate Maximum
LineOfCreditBasisSpreadOnCanadianPrimeRateMaximum
0.03125 Rate
CY2020 mtrx Senior Leverage Ratio Maximum
SeniorLeverageRatioMaximum
3.00
CY2020 mtrx Senior Leverage Ratio Minimum
SeniorLeverageRatioMinimum
1.00
CY2020 mtrx Fixed Charge Coverage Ratio Maximum
FixedChargeCoverageRatioMaximum
1.25
CY2020 mtrx Fixed Charge Coverage Ratio Minimum
FixedChargeCoverageRatioMinimum
1.00
CY2020 mtrx Amount Of Limit On Asset Dispositions
AmountOfLimitOnAssetDispositions
20.0 USD
CY2020Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
300000000 USD
CY2019Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
300000000 USD
CY2020Q2 mtrx Capacity Constraint Due To Senior Leverage Ratio
CapacityConstraintDueToSeniorLeverageRatio
162864000 USD
CY2019Q2 mtrx Capacity Constraint Due To Senior Leverage Ratio
CapacityConstraintDueToSeniorLeverageRatio
94323000 USD
CY2020Q2 mtrx Line Of Credit Facility Maximum Borrowing Capacity After Consideration Of Capacity Constraint
LineOfCreditFacilityMaximumBorrowingCapacityAfterConsiderationOfCapacityConstraint
137136000 USD
CY2019Q2 mtrx Line Of Credit Facility Maximum Borrowing Capacity After Consideration Of Capacity Constraint
LineOfCreditFacilityMaximumBorrowingCapacityAfterConsiderationOfCapacityConstraint
205677000 USD
CY2020Q2 mtrx Letters Of Credit Issued
LettersOfCreditIssued
34529000 USD
CY2019Q2 mtrx Letters Of Credit Issued
LettersOfCreditIssued
48147000 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
9208000 USD
CY2019Q2 us-gaap Line Of Credit
LineOfCredit
5347000 USD
CY2020Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
93399000 USD
CY2020Q1 mtrx Cares Act Charitable Contributions Deduction New Ceiling
CARESActCharitableContributionsDeductionNewCeiling
0.25
CY2020Q1 mtrx Cares Act Charitable Contributions Deduction Old Ceiling
CARESActCharitableContributionsDeductionOldCeiling
0.10
CY2019Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
152183000 USD
CY2020Q1 mtrx Cares Act Total Benefit
CARESActTotalBenefit
2200000000000 USD
CY2020Q1 mtrx Taxable Income Limitation Required For Net Operating Loss Carryforwards
TaxableIncomeLimitationRequiredForNetOperatingLossCarryforwards
0.80
CY2020Q1 mtrx Cares Act Interest Expense Deduction Upper Limit
CARESActInterestExpenseDeductionUpperLimit
0.50
CY2020Q1 mtrx Cares Act Interest Expense Deduction Floor
CARESActInterestExpenseDeductionFloor
0.30
CY2020 mtrx Cares Act Payroll Tax Credits
CARESActPayrollTaxCredits
800000 USD
CY2020Q2 mtrx Caresact Deferred Payroll Tax Liability
CARESACTDeferredPayrollTaxLiability
3800000 USD
CY2020 mtrx Canada Emergency Wage Subsidy Relief
CanadaEmergencyWageSubsidyRelief
1100000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-32660000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
46032000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2656000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-3984000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-7620000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-9492000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36644000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38412000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12148000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-376000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6085000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-121000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
412000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2390000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
135000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
23000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-97000 USD
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
504000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
59000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8378000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
518000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5000000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-528000 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1093000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1091000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
451000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-590000 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
2462000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
2129000 USD
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1689000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3629000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2052000 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2288000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1186000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3570000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10430000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-668000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7695000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
8067000 USD
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3408000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-768000 USD
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
247000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
1813000 USD
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0 USD
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
2342000 USD
CY2020 mtrx Income Tax Reconciliation Charges Without Tax Benefit
IncomeTaxReconciliationChargesWithoutTaxBenefit
-1707000 USD
CY2019 mtrx Income Tax Reconciliation Charges Without Tax Benefit
IncomeTaxReconciliationChargesWithoutTaxBenefit
-1233000 USD
CY2018 mtrx Income Tax Reconciliation Charges Without Tax Benefit
IncomeTaxReconciliationChargesWithoutTaxBenefit
-1100000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3062000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4512000 USD
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1173000 USD
CY2020 mtrx Reversalofbranchliability
Reversalofbranchliability
0 USD
CY2019 mtrx Reversalofbranchliability
Reversalofbranchliability
-3546000 USD
CY2018 mtrx Reversalofbranchliability
Reversalofbranchliability
0 USD
CY2020 mtrx Effectofnewaccountingstandardcomparedtooldstandard
Effectofnewaccountingstandardcomparedtooldstandard
-230000 USD
CY2019 mtrx Effectofnewaccountingstandardcomparedtooldstandard
Effectofnewaccountingstandardcomparedtooldstandard
296000 USD
CY2018 mtrx Effectofnewaccountingstandardcomparedtooldstandard
Effectofnewaccountingstandardcomparedtooldstandard
-511000 USD
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
0 USD
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
0 USD
CY2018 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-455000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1724000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1972000 USD
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1665000 USD
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-132000 USD
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-248000 USD
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-10000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
20000 USD
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-496000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3570000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
22000 USD
CY2018 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
-7000 USD
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-83000 USD
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
370000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10430000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-668000 USD
CY2020 mtrx Amount Of Non Deductible Goodwill Impaired
AmountOfNonDeductibleGoodwillImpaired
8600000 USD
CY2018 mtrx Amount Of Non Deductible Goodwill Impaired
AmountOfNonDeductibleGoodwillImpaired
8300000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
206000 USD
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
206000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
233000 USD
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
238000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
669000 USD
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
616000 USD
CY2020Q2 mtrx Deferred Tax Assets Insurance Reserve
DeferredTaxAssetsInsuranceReserve
1221000 USD
CY2019Q2 mtrx Deferred Tax Assets Insurance Reserve
DeferredTaxAssetsInsuranceReserve
1577000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
207000 USD
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
1000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
10354000 USD
CY2019Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
10054000 USD
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7763000 USD
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4959000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
1447000 USD
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
1115000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3231000 USD
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3679000 USD
CY2020Q2 mtrx Deferred Tax Assets Accrued Losses
DeferredTaxAssetsAccruedLosses
96000 USD
CY2019Q2 mtrx Deferred Tax Assets Accrued Losses
DeferredTaxAssetsAccruedLosses
194000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
1381000 USD
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
0 USD
CY2020Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
843000 USD
CY2019Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
833000 USD
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12125000 USD
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
13554000 USD
CY2020Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
11313000 USD
CY2019Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
9349000 USD
CY2020Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
-5195000 USD
CY2019Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
1770000 USD
CY2020Q2 mtrx Future Branch Liability
FutureBranchLiability
74000 USD
CY2019Q2 mtrx Future Branch Liability
FutureBranchLiability
34000 USD
CY2020Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
6000 USD
CY2019Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
16000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6198000 USD
CY2019Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
11169000 USD
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
5927000 USD
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2385000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3978000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5988000 USD
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2683000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
61000 USD
CY2019Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
298000 USD
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
5927000 USD
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2385000 USD
CY2020Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
500000 USD
CY2020Q2 us-gaap Unapproved Change Orders Amount
UnapprovedChangeOrdersAmount
14500000 USD
CY2019Q2 us-gaap Unapproved Change Orders Amount
UnapprovedChangeOrdersAmount
10100000 USD
CY2020Q2 us-gaap Contracts Receivable Claims And Uncertain Amounts
ContractsReceivableClaimsAndUncertainAmounts
17800000 USD
CY2020Q2 mtrx Percentage Of Real Estate Leases
PercentageOfRealEstateLeases
0.87
CY2020Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P16Y
CY2020 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3200000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
12274000 USD
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
37371000 USD
CY2020 us-gaap Lease Cost
LeaseCost
49645000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8719000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5430000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3010000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2352000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
9630000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33119000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
-5554000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
27565000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7568000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19997000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y2M12D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
12798000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
36984000 USD
CY2020 us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
2500000 USD
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0 USD
CY2020 mtrx Percentageofoutstandingsharesusedtodeterminemaximumsharesauthorizedundersharerepurchaseprogram
Percentageofoutstandingsharesusedtodeterminemaximumsharesauthorizedundersharerepurchaseprogram
0.10
CY2020Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2700000 shares
CY2020 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1047606 shares
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17000000.0 USD
CY2020Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
1349037 shares
CY2020 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
181081 shares
CY2019 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
79111 shares
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1746689 shares
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
9900000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
11900000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
8600000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11900000 USD
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
200000 USD
CY2018 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
500000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1600000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1473424 shares
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
53700 shares
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M24D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.19
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
541000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.19
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
53700 shares
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y4M24D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.19
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
53700 shares
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y4M24D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
53700 shares
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y4M24D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.19
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000 USD
CY2020Q2 mtrx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Method Numberof Simulations Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMethodNumberofSimulationsUsed
100000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1459511 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.88
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
490322 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.79
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
542279 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
19.43
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
172636 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
19.51
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1234918 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.89
CY2019 mtrx Share Based Compensation Arrangement By Share Based Payment Award Deferred Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredGrantsInPeriod
602148 shares
CY2018 mtrx Share Based Compensation Arrangement By Share Based Payment Award Deferred Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredGrantsInPeriod
715539 shares
CY2019 mtrx Share Based Compensation Arrangement By Share Based Payment Award Deferred Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredWeightedAverageGrantDateFairValue
25.10
CY2018 mtrx Share Based Compensation Arrangement By Share Based Payment Award Deferred Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredWeightedAverageGrantDateFairValue
13.64
CY2019 mtrx Share Based Compensation Arrangement By Share Based Payment Award Deferred Shares Vested And Released
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredSharesVestedAndReleased
314711 shares
CY2018 mtrx Share Based Compensation Arrangement By Share Based Payment Award Deferred Shares Vested And Released
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredSharesVestedAndReleased
253241 shares
CY2019 us-gaap Net Income Loss
NetIncomeLoss
27982000 USD
CY2019Q2 mtrx Share Based Compensation Arrangement By Share Based Payment Award Deferred Shares Vested And Released Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredSharesVestedAndReleasedWeightedAverageGrantDateFairValue
16.23
CY2018Q2 mtrx Share Based Compensation Arrangement By Share Based Payment Award Deferred Shares Vested And Released Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredSharesVestedAndReleasedWeightedAverageGrantDateFairValue
19.60
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-33074000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-11480000 USD
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26621000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26891000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26769000 shares
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26621000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26891000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26769000 shares
CY2019 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
668000 shares
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
28000 shares
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2020 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0 shares
CY2018 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26621000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27587000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26769000 shares
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
681000 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
160000 shares
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
455000 shares
CY2020 mtrx Defined Contribution Plan Maximum Annual Contribution By Employee Percent
DefinedContributionPlanMaximumAnnualContributionByEmployeePercent
0.25
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
1
CY2020 mtrx Percentage Of Employee Contribution As Base For Employer Contributions
PercentageOfEmployeeContributionAsBaseForEmployerContributions
0.03
CY2020 mtrx Defined Contribution Plan Employer Matching Contribution Percent For Two Percent Of Employee Contribution
DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution
0.50
CY2020 mtrx Percentage Of Employee Contribution As Base For Employer Contribution To Match
PercentageOfEmployeeContributionAsBaseForEmployerContributionToMatch
0.02
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6200000 USD
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5800000 USD
CY2020 us-gaap Multiemployer Plan Pension Insignificant Employer Contribution Cost
MultiemployerPlanPensionInsignificantEmployerContributionCost
9172000 USD
CY2020 us-gaap Multiemployer Plan Pension Insignificant Employer Contribution Cost
MultiemployerPlanPensionInsignificantEmployerContributionCost
9172000 USD
CY2020 us-gaap Multiemployer Plan Pension Insignificant Employer Contribution Cost
MultiemployerPlanPensionInsignificantEmployerContributionCost
9172000 USD
CY2019 us-gaap Multiemployer Plan Pension Insignificant Employer Contribution Cost
MultiemployerPlanPensionInsignificantEmployerContributionCost
15019000 USD
CY2018 us-gaap Multiemployer Plan Pension Insignificant Employer Contribution Cost
MultiemployerPlanPensionInsignificantEmployerContributionCost
15152000 USD
CY2020 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
37403000 USD
CY2019 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
64386000 USD
CY2018 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
54724000 USD
CY2020 mtrx Employee Stock Purchase Plan Maximum Annual Share Purchase Limited To Aggregate Market Value
EmployeeStockPurchasePlanMaximumAnnualSharePurchaseLimitedToAggregateMarketValue
60000 USD
CY2020 mtrx Employee Stock Purchase Plan Maximum Number Of Shares Available For Issuance
EmployeeStockPurchasePlanMaximumNumberOfSharesAvailableForIssuance
1000000 shares
CY2020 mtrx Employee Stock Purchase Plan Termination Date
EmployeeStockPurchasePlanTerminationDate
2021-01-02
CY2020 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
20733 shares
CY2019 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
15812 shares
CY2018 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
21920 shares
CY2020 mtrx Grossrevenues
Grossrevenues
1107560000 USD
CY2020 us-gaap Revenues
Revenues
1100938000 USD
CY2020 us-gaap Gross Profit
GrossProfit
102176000 USD
CY2020 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
52525000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-36625000 USD
CY2020Q2 us-gaap Assets
Assets
517310000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18539000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19124000 USD
CY2019 mtrx Grossrevenues
Grossrevenues
1421276000 USD
CY2019 us-gaap Revenues
Revenues
1416680000 USD
CY2019 us-gaap Gross Profit
GrossProfit
131951000 USD
CY2019 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
37930000 USD
CY2019Q2 us-gaap Assets
Assets
633394000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19558000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18224000 USD
CY2018 mtrx Grossrevenues
Grossrevenues
1097738000 USD
CY2018 us-gaap Revenues
Revenues
1091553000 USD
CY2018 us-gaap Gross Profit
GrossProfit
91936000 USD
CY2018 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
17998000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-10479000 USD
CY2018Q2 us-gaap Assets
Assets
558033000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8711000 USD
CY2019Q2 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20347000 USD
CY2020Q2 us-gaap Noncurrent Assets
NoncurrentAssets
182150000 USD
CY2019Q2 us-gaap Noncurrent Assets
NoncurrentAssets
216084000 USD
CY2018Q2 us-gaap Noncurrent Assets
NoncurrentAssets
200987000 USD
CY2020 us-gaap Severance Costs1
SeveranceCosts1
8775000 USD
CY2020 us-gaap Business Exit Costs1
BusinessExitCosts1
3710000 USD
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
1525000 USD
CY2020Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
6559000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
14010000 USD
CY2020 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
5215000 USD
CY2020 us-gaap Payments For Restructuring
PaymentsForRestructuring
-6392000 USD
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
2403000 USD
CY2019Q3 us-gaap Revenues
Revenues
338097000 USD
CY2019Q4 us-gaap Revenues
Revenues
318677000 USD
CY2020Q1 us-gaap Revenues
Revenues
248327000 USD
CY2020Q2 us-gaap Revenues
Revenues
195837000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
32465000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
30001000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
20477000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
19233000 USD
CY2019Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 USD
CY2019Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
38515000 USD
CY2020Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
7451000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8774000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-31679000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5800000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7920000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
6151000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-28008000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5495000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5722000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.04
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2018Q3 us-gaap Revenues
Revenues
318511000 USD
CY2018Q4 us-gaap Revenues
Revenues
340568000 USD
CY2019Q1 us-gaap Revenues
Revenues
358887000 USD
CY2019Q2 us-gaap Revenues
Revenues
398714000 USD
CY2018Q3 us-gaap Gross Profit
GrossProfit
23421000 USD
CY2018Q4 us-gaap Gross Profit
GrossProfit
27886000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
36906000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
43738000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2220000 USD
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
5527000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12794000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
17389000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
2305000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
3932000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8933000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
12812000 USD
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2019Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
5882000 USD
CY2020 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
4220000 USD
CY2020 us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
0 USD
CY2020 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
1434000 USD
CY2020Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
8668000 USD
CY2018Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
7965000 USD
CY2019 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
4599000 USD
CY2019 us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
0 USD
CY2019 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
6682000 USD
CY2019Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
5882000 USD
CY2017Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
11606000 USD
CY2018 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
1127000 USD
CY2018 us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
0 USD
CY2018 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
4768000 USD
CY2018Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
7965000 USD

Files In Submission

Name View Source Status
0000866273-20-000109-index-headers.html Edgar Link pending
0000866273-20-000109-index.html Edgar Link pending
0000866273-20-000109.txt Edgar Link pending
0000866273-20-000109-xbrl.zip Edgar Link pending
exhibit1014.htm Edgar Link pending
exhibit1015.htm Edgar Link pending
exhibit21-mtrxx2020x06.htm Edgar Link pending
exhibit23-mtrxx2020x06.htm Edgar Link pending
exhibit311-mtrxx2020x0.htm Edgar Link pending
exhibit312-mtrxx202006.htm Edgar Link pending
exhibit321-mtrxx2020x0.htm Edgar Link pending
exhibit322-mtrxx2020x0.htm Edgar Link pending
exhibit95-mtrxx2020x06.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mtrx-20200630.htm Edgar Link pending
mtrx-20200630.xsd Edgar Link pending
mtrx-20200630_cal.xml Edgar Link unprocessable
mtrx-20200630_def.xml Edgar Link unprocessable
mtrx-20200630_g1.jpg Edgar Link pending
mtrx-20200630_htm.xml Edgar Link completed
mtrx-20200630_lab.xml Edgar Link unprocessable
mtrx-20200630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending